Anti-IL5 therapies for chronic obstructive pulmonary disease

Donovan, T. and Crossingham, I. and Milan, S.J. and Wang, R. and Bradley, P. (2019) Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2019 (9). ISSN 1469-493X

[img]
Text (Donovan_et_al-2019-Cochrane_Database_of_Systematic_Reviews)
Donovan_et_al_2019_Cochrane_Database_of_Systematic_Reviews.pdf - Published Version
Restricted to Repository staff only until 20 September 2020.
Available under License Creative Commons Attribution-NonCommercial.

Download (181kB)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

Item Type:
Journal Article
Journal or Publication Title:
Cochrane Database of Systematic Reviews
Additional Information:
This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700
Subjects:
ID Code:
137754
Deposited By:
Deposited On:
11 Oct 2019 08:35
Refereed?:
Yes
Published?:
Published
Last Modified:
27 Mar 2020 04:24